Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance
Abstract Background Mortality rates for patients with Staphylococcus aureus (S. aureus) infections have improved only modestly in recent decades and S. aureus infections remain a major clinical challenge This study investigated the in vitro antimicrobial activity of erevacycline (erava) against clin...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Microbiology |
Online Access: | http://link.springer.com/article/10.1186/s12866-018-1349-7 |